Fulgent Genetics (FLGT)
(Real Time Quote from BATS)
$20.26 USD
+0.23 (1.15%)
Updated Apr 26, 2024 12:22 PM ET
3-Hold of 5 3
C Value B Growth C Momentum B VGM
Price, Consensus and EPS Surprise
FLGT 20.26 +0.23(1.15%)
Will FLGT be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for FLGT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for FLGT
Privia Health (PRVA) Misses Q4 Earnings Estimates
Health Catalyst (HCAT) Q4 Earnings and Revenues Beat Estimates
FLGT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Fulgent Genetics, Inc. (FLGT) Reports Q3 Loss, Tops Revenue Estimates
Strength Seen in Olink Holding AB (publ) Sponsored ADR (OLK): Can Its 66.0% Jump Turn into More Strength?
Fulgent Genetics, Inc. (FLGT) Reports Q2 Loss, Tops Revenue Estimates
Other News for FLGT
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
What's Driving Twist Bioscience Corp's Surprising 44% Stock Rally?
Piper Sandler Sticks to Its Hold Rating for Fulgent Genetics (FLGT)
Fulgent Genetics price target lowered by $3 at Piper Sandler, here's why
Fulgent Genetics (FLGT) Q4 2023 Earnings Call Transcript